Acurx Pharmaceuticals Inc (ACXP)

14000 Shares in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Bought by NBC Securities Inc. - Defense World

Defense World

How Do Things Look For Acurx Pharmaceuticals Inc (NASDAQ: ACXP) In The Short-Term? – Stocks Register - Stocks Register

Stocks Register

Closing Strong: Acurx Pharmaceuticals Inc (ACXP) Ends at 2.25, Down -5.46 from Last Close – DWinneX - The Dwinnex

The Dwinnex

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Significant Growth in Short Interest - Defense World

Defense World

Acurx Pharmaceuticals (NASDAQ:ACXP) Trading Up 6.3% - Defense World

Defense World

Acurx Pharmaceuticals (NASDAQ:ACXP) Trading Up 6.3% - Defense World

Defense World

New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored ... - GlobeNewswire

GlobeNewswire

New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored ... - Yahoo Canada Finance

Yahoo Canada Finance

12 Health Care Stocks Moving In Tuesday's After-Market Session - Acurx Pharmaceuticals (NASDAQ:ACXP), Biodexa ... - Benzinga

Benzinga

Q2 2024 Earnings Forecast for Cabaletta Bio, Inc. Issued By HC Wainwright (NASDAQ:CABA) - Defense World

Defense World

HC Wainwright Reiterates Buy Rating for Acurx Pharmaceuticals (NASDAQ:ACXP) - Defense World

Defense World

Acurx reports results from meeting with FDA regarding ibezapolstat - TipRanks

TipRanks

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Short Interest in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Rises By 6.3% - Defense World

Defense World

Short Interest in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Rises By 6.3% - Defense World

Defense World

Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress - Investing.com ZA - Investing.com South Africa

Investing.com South Africa

Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress - Investing.com India

Investing.com India

Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress - Investing.com India

Investing.com India

Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress By Investing.com - Investing.com

Investing.com

Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress By Investing.com - Investing.com UK

Investing.com UK

Acurx gears up for Phase 3 trials of CDI antibiotic candidate - Investing.com Australia

Investing.com Australia

Acurx gears up for Phase 3 trials of CDI antibiotic candidate - Investing.com South Africa

Investing.com South Africa

Acurx Pharmaceuticals Reports First Quarter 2024 Results and Provides Business Update - citybiz

citybiz

Acurx Pharmaceuticals, Inc. (ACXP) Q1 2024 Earnings Call Transcript - Seeking Alpha

Seeking Alpha

Acurx gears up for Phase 3 trials of CDI antibiotic candidate - Investing.com

Investing.com

Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress By Investing.com - Investing.com

Investing.com

Infectious disease index continues decline despite positive news - BioWorld Online

BioWorld Online

Infectious disease index continues decline despite positive news - BioWorld Online

BioWorld Online

Acurx Pharmaceuticals (ACXP) Scheduled to Post Quarterly Earnings on Wednesday - Defense World

Defense World

Lion Electric reports US$21.7M Q1 loss compared with US$15.6M loss a year earlier - Yahoo News Canada

Yahoo News Canada

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results - Yahoo Canada Finance

Yahoo Canada Finance

CaliberCos (CWD) versus Its Rivals Critical Comparison - Defense World

Defense World

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Benzinga

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Markets Insider

Markets Insider

Acurx Pharmaceuticals, Inc. Rings the Nasdaq Stock Market Closing Bell - Nasdaq

Nasdaq

La Rosa Holdings Corp. Rings the Nasdaq Stock Market Closing Bell - Nasdaq

Nasdaq

Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks - Insider Monkey

Insider Monkey

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Acurx Pharmaceuticals Inc Down 1.84% To $2.67 After Earnings Miss - InvestorsObserver

InvestorsObserver

Acurx Pharmaceuticals Shares Fall 26% On Stock-Offering News - MarketWatch

MarketWatch

Feyi-Waboso out of England Six Nations camp to take uni exam - Yahoo Finance UK

Yahoo Finance UK

New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series - GlobeNewswire

GlobeNewswire

New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network ... - Yahoo Finance

Yahoo Finance

New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday ... - GlobeNewswire

GlobeNewswire

Acurx Stock: Sell-off Presents Opportunity Before Upcoming Data Release - Seeking Alpha

Seeking Alpha

Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today? - Yahoo Finance

Yahoo Finance

Why Acurx Pharmaceuticals (ACXP) Shares Are Falling Today - Acurx Pharmaceuticals (NASDAQ:ACXP) - Benzinga

Benzinga

New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored ... - Yahoo Finance

Yahoo Finance

Acurx Undervalued And Set For Potential M&A With Next-Gen C. Diff Treatment (NASDAQ:ACXP) - Seeking Alpha

Seeking Alpha